Elisabeth Lambert

Elisabeth Lambert is a Senior Research Fellow at Swinburne University of Technology, affiliated with the School of Health Science and the Iverson Health Innovation Research Institute. She previously worked at the Baker Heart and Diabetes Institute for 18 years. Her research focuses on cardiovascular and metabolic diseases, particularly the role of the sympathetic nervous system in conditions like hypertension, obesity, type-2 diabetes, and intellectual disability-related cardiometabolic risks. She has published over 220 papers and secured 12 NHMRC grants. Recent achievements include refining techniques for identifying brain areas linked to muscle sympathetic nerve activity and demonstrating links between sympathetic activity and vascular aging in anorexia nervosa patients.

Education: PhD from the University of Paris, France.

Research Interests: Mechanisms of cardiovascular and metabolic disorders, sympathetic nervous system regulation, clinical applications of neuroimaging (MEG, MRI), and translational research in hypertension and obesity. Key areas include stress-induced cardiovascular responses, renal denervation efficacy, and the impact of loneliness on vascular health.

Publications: Recent work highlights brain-sympathetic interactions in stress, long-term outcomes of renal denervation, and the role of microRNAs in metabolic diseases. Articles span neurophysiology, cardiovascular risk factors, and translational clinical studies.

Advising & Grants: Supervised 7 PhD students on topics like brain pathways in hypertension, vagus nerve stimulation, and cardiometabolic risks in intellectual disability. NHMRC grants support her research on sympathetic nervous system dysregulation.

Labs/Teams: MedTechVic and the Iverson Health Innovation Research Institute, focusing on interdisciplinary health solutions.